CAS: 1415925-18-6
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
GSK2795039 REF: TM-T15433CAS: 1415925-18-6 | 98.68% | 72.00 €~874.00 € | Tue 11 Jun 24 | |
GSK2795039 REF: AN-AG009CN0CAS: 1415925-18-6 | 97% | 54.00 €~857.00 € | Tue 11 Jun 24 | |
GSK2795039 REF: 3D-QGC92518CAS: 1415925-18-6 | Min. 95% | To inquire | Tue 23 Jul 24 |
GSK2795039
CAS:1415925-18-6
GSK2795039 inhibits reactive oxygen species (ROS) production and NADPH consumption. GSK2795039 decreases apoptosis. GSK2795039 is …
Formula:
C23H26N6O2S
Purity:
98.68%
Color and Shape:
Solid
Molecular weight:
450.56
Ref: TM-T15433
1mg | 72.00 € | ||
2mg | 95.00 € | ||
5mg | 158.00 € | ||
10mg | 239.00 € | ||
25mg | 420.00 € | ||
50mg | 613.00 € | ||
100mg | 874.00 € | ||
1ml*10 (DMSO) | 171.00 € |
Estimated delivery in United States, on Tuesday 11 Jun 2024
GSK2795039
CAS:1415925-18-6
Formula:
C23H26N6O2S
Purity:
97%
Color and Shape:
Solid
Molecular weight:
450.5565
Ref: AN-AG009CN0
1mg | 54.00 € | ||
25mg | 190.00 € | ||
50mg | 320.00 € | ||
100mg | 511.00 € |
Estimated delivery in United States, on Tuesday 11 Jun 2024
GSK2795039
CAS:1415925-18-6
GSK2795039 is a molecule that may be a potential therapeutic for hypoxic tumours. GSK2795039 inhibits …
Formula:
C23H26N6O2S
Purity:
Min. 95%
Molecular weight:
450.56 g/mol
Ref: 3D-QGC92518
1mg | To inquire | ||
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire |
Estimated delivery in United States, on Tuesday 23 Jul 2024